181
Views
21
CrossRef citations to date
0
Altmetric
Original Research

Self-nanoemulsifying drug-delivery systems for potentiated anti-inflammatory activity of diacerein

, , &
Pages 6585-6602 | Published online: 18 Oct 2018

References

  • AlcarazMJMegíasJGarcía-ArnandisIClériguesVGuillénMINew molecular targets for the treatment of osteoarthritisBiochem Pharmacol2010801132120206140
  • BerenbaumFTargeted therapies in osteoarthritis: a systematic review of the trials on www.clinicaltrials.govBest Pract Res Clin Rheumatol201024110711920129204
  • SostresCGargalloCJArroyoMTLanasAAdverse effects of non-steroidal anti-inflammatory drugs (NSAIDs, aspirin and coxibs) on upper gastrointestinal tractBest Pract Res Clin Gastroenterol201024212113220227026
  • JainASinghRSinghSSinghSDiacerein protects against iodoacetate-induced osteoarthritis in the femorotibial joints of ratsJ Biomed Res201529540541326442595
  • DougadosMNguyenMBerdahLMaziéresBVignonELequesneMECHODIAH investigators study group. evaluation of the structure-modifying effects of diacerein in hip osteoarthritis: ECHODIAH, a three-year, placebo-controlled trialArthritis Rheum200144112539254711710710
  • BartelsEMBliddalHSchøndorffPKAltmanRDZhangWChristensenRSymptomatic efficacy and safety of diacerein in the treatment of osteoarthritis: a meta-analysis of randomized placebo-controlled trialsOsteoarthritis Cartilage201018328929619857509
  • PavelkaKBruyèreOCooperCDiacerein: benefits, risks and place in the management of osteoarthritis. An opinion-based report from the ESCEODrugs Aging2016332758526849131
  • ElsayedIAbdelbaryAAElshafeeyAHNanosizing of a poorly soluble drug: technique optimization, factorial analysis, and pharmacokinetic study in healthy human volunteersInt J Nanomedicine201492943295324971006
  • YamauchiKYagiTKuwanoSSuppression of the purgative action of rhein anthrone, the active metabolite of sennosides A and B, by calcium channel blockers, calmodulin antagonists and indomethacinPharmacology199347Suppl 1(1)22318234433
  • AggarwalAKSinghSPhysicochemical characterization and dissolution study of solid dispersions of diacerein with polyethylene glycol 6000Drug Dev Ind Pharm201137101181119121449824
  • ZakiRMAliAAEl MenshawiSFBaryAAEffect of binary and ternary solid dispersions prepared by fusion method on the dissolution of poorly water-soluble diacereinInt J Drug Del20135199109
  • PatilSBSheteDKNaradeSBImprovement in the dissolution profile of diacerein using a surfactant-based solid dispersion techniqueDrug Discov Ther20104643544122491309
  • GartheOMKothawadePSMahajanVRSolubility Enhancement of diacerein by solid dispersion techniqueInt J Pharm Res Allied Sci2013224755
  • NakhatPMandaogadePJainGKNo TMUS20100303902A1Washington, DCUS Patent and Trademark Office2010
  • AggarwalAKSinghSFast-dissolving and high-drug-loaded, Fatty Acid-based self-emulsifying solid dispersions of diacereinPDA J Pharm Sci Technol201266320121322634586
  • NazzalSSmalyukhIILavrentovichODKhanMAPreparation and in vitro characterization of a eutectic based semisolid self-nanoemulsified drug delivery system (SNEDDS) of ubiquinone: mechanism and progress of emulsion formationInt J Pharm20022351–224726511879759
  • PoutonCWFormulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification systemEur J Pharm Sci2006293–427828716815001
  • SharmaASharmaUSLiposomes in drug delivery: Progress and limitationsInt J Pharm19971542123140
  • MüllerRHMäderKGohlaSSolid lipid nanoparticles (SLN) for controlled drug delivery–a review of the state of the artEur J Pharm Biopharm200050116117710840199
  • MahmoudEABendasERMohamedMIPreparation and evaluation of self-nanoemulsifying tablets of carvedilolAAPS PharmSciTech200910118319219238556
  • PoutonCWLipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and ‘self-microemulsifying’ drug delivery systemsEur J Pharm Sci200011Suppl 2(2)S93S9811033431
  • O’DriscollCMLipid-based formulations for intestinal lymphatic deliveryEur J Pharm Sci200215540541512036717
  • PorterCJTrevaskisNLCharmanWNLipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugsNat Rev Drug Discov20076323124817330072
  • ChambinOJanninVInterest of multifunctional lipid excipients: case of Gelucire 44/14Drug Dev Ind Pharm200531652753416109625
  • JanninVMusakhanianJMarchaudDApproaches for the development of solid and semi-solid lipid-based formulationsAdv Drug Deliv Rev200860673474618045728
  • BarakatNSEtodolac-liquid-filled dispersion into hard gelatin capsules: an approach to improve dissolution and stability of etodolac formulationDrug Dev Ind Pharm200632786587616908424
  • SolimanMSKhanMAPreparation and in vitro characterization of a semi-solid dispersion of flurbiprofen with Gelucire 44/14 and LabrasolPharmazie200560428829315881610
  • EedaraBBVeerareddyPRJukantiRBandariSImproved oral bioavailability of fexofenadine hydrochloride using lipid surfactants: ex vivo, in situ and in vivo studiesDrug Dev Ind Pharm20144081030104323738504
  • VarmaMVPanchagnulaREnhanced oral paclitaxel absorption with vitamin E-TPGS: effect on solubility and permeability in vitro, in situ and in vivoEur J Pharm Sci2005254–544545315890503
  • FulzeleSVChatterjeeAShaikMSJacksonTSinghMInhalation delivery and anti-tumor activity of celecoxib in human orthotopic non-small cell lung cancer xenograft modelPharm Res20062392094210616902813
  • SaidiZKlyashchitskyBUS Patent6,241,969 B1Washington, DCU.S. Patent and Trademark Office2001
  • NikonenkoBVReddyVMProtopopovaMBogatchevaEEinckLNacyCAActivity of SQ641, a capuramycin analog, in a murine model of tuberculosisAntimicrob Agents Chemother20095373138313919414567
  • MomotKIKuchelPWChapmanBEDeoPWhittakerDNMR Study of the Association of Propofol with Nonionic SurfactantsLangmuir200319620882095
  • GuoYLuoJTanSOtienoBOZhangZThe applications of Vitamin E TPGS in drug deliveryEur J Pharm Sci201349217518623485439
  • ChristiansenABackensfeldTKühnSWeitschiesWInvestigating the stability of the nonionic surfactants tocopheryl polyethylene glycol succinate and sucrose laurate by HPLC-MS, DAD, and CADJ Pharm Sci201110051773178221374613
  • ZhangZTanSFengSSVitamin E TPGS as a molecular biomaterial for drug deliveryBiomaterials201233194889490622498300
  • AhujaNKatareOPSinghBStudies on dissolution enhancement and mathematical modeling of drug release of a poorly water-soluble drug using water-soluble carriersEur J Pharm Biopharm2007651263816962750
  • MohamedEAMeshaliMMFodaAMBorgTMImprovement of dissolution and hypoglycemic efficacy of glimepiride by different carriersAAPS PharmSciTech20121331013102322843078
  • AbdelkaderHAbdallahOYSalemHSComparison of the effect of tromethamine and polyvinylpyrrolidone on dissolution properties and analgesic effect of nimesulideAAPS PharmSciTech200783E110E11718181531
  • MartinANSwarbrickJCammarataAPhysical Pharmacy: Physical Chemical Principles in The Pharmaceutical Sciences4Lea, FebigerPhiladelphia1993
  • HiguchiTMechanismof of sustained-action medication. theoretical analysis of rate of release of solid drugs dispersed in solid matricesJ Pharm Sci196352121145114914088963
  • RitgerPLPeppasNAA simple equation for description of solute release I. Fickian and non-fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discsJournal of Controlled Release1987512336
  • MeiZLiXWuQHuSYangXThe research on the anti-inflammatory activity and hepatotoxicity of triptolide-loaded solid lipid nanoparticlePharmacol Res200551434535115683748
  • BancroftJDGambleMTheory and Practice of Histological Techniques5Livingstone ChurchillLondon UK2007125138
  • RiellaKRMarinhoRRSantosJSAnti-inflammatory and cicatrizing activities of thymol, a monoterpene of the essential oil from Lippia gracilis, in rodentsJ Ethnopharmacol2012143265666322885071
  • El-SheakhARGhoneimHASuddekGMAmmarEl-SmAntioxidant and anti-inflammatory effects of flavocoxid in high-cholesterol-fed rabbitsNaunyn Schmiedebergs Arch Pharmacol2015388121333134426341793
  • MohamedEAAbu HashimIIYusifRMPolymeric micelles for potentiated antiulcer and anticancer activities of naringinInt J Nanomedicine2018131009102729497294
  • FisherERAndersonSDeanSSolving the dilemma of the immunohistochemical and other methods used for scoring estrogen receptor and progesterone receptor in patients with invasive breast carcinomaCancer2005103116417315565575
  • B P British PharmacopeiaIII6LondonThe Council of Europe, The Stationary Office201031553157
  • SilversteinRMBasslerGCMorrillTCSpectroscopic Identification of Organic Compounds5Wiley, John, Sons IncNY USA1991
  • FaisalWRuane-O’HoraTO’DriscollCMGriffinBTA novel lipid-based solid dispersion for enhancing oral bioavailability of Lycopene – in vivo evaluation using a pig modelInt J Pharm2013453230731423796833
  • ShinSCKimJPhysicochemical characterization of solid dispersion of furosemide with TPGSInt J Pharm20032511–2798412527177
  • OfokansiKCAdikwuMUOkoreVCPreparation and evaluation of mucin-gelatin mucoadhesive microspheres for rectal delivery of ceftriaxone sodiumDrug Dev Ind Pharm200733669170017613033
  • AllenCMaysingerDEisenbergANano-engineering block copolymer aggregates for drug deliveryColloids Surf B Biointerfaces1999161–4327
  • BayindirZSYukselNCharacterization of niosomes prepared with various nonionic surfactants for paclitaxel oral deliveryJ Pharm Sci20109942049206019780133
  • FissanHRistigSKaminskiHAsbachCEppleMComparison of different characterization methods for nanoparticle dispersions before and after aerosolizationAnalytical Methods201461873247334
  • EatonPQuaresmaPSoaresCA direct comparison of experimental methods to measure dimensions of synthetic nanoparticlesUltramicroscopy201718217919028692935